Morgan Stanley Miromatrix Medical Inc. Transaction History

Morgan Stanley

  • $1.27 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Oct 27, 2022
SELL
$3.36 - $4.32 $1,703 - $2,190
-507 Reduced 33.64%
1,000 $4,000
Q2 2022

Aug 15, 2022
SELL
$3.36 - $4.32 $1,703 - $2,190
-507 Reduced 33.64%
1,000 $4,000
Q1 2022

Oct 27, 2022
BUY
$2.03 - $4.73 $1,029 - $2,398
507 Added 50.7%
1,507 $6,000
Q1 2022

May 13, 2022
BUY
$2.03 - $4.73 $3,059 - $7,128
1,507 New
1,507 $6,000

About Miromatrix Medical Inc.

MIRO Quotes by TradingView
  • Ticker MIRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,899,200
  • Description
  • Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...
More about MIRO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email